Development of second primary malignancies after transoral surgery in human papilloma virus‐positive oropharyngeal squamous cell carcinoma
Head & Neck2022Vol. 44(5), pp. 1069–1078
Citations Over TimeTop 15% of 2022 papers
Katelyn O. Stepan, Ethan J. Craig, S. Andrew Skillington, Brian C. Deutsch, Stephanie Chen, Nneoma S. Wamkpah, Craig A. Bollig, Dorina Kallogjeri, Wade L. Thorstad, Sidharth V. Puram, Patrik Pipkorn, Ryan S. Jackson
Abstract
The rate of SPM among patients with HPV-positive OPSCC is lower than reported rates among HPV-negative OPSCC. To date, this is the largest study evaluating SPM in patients with surgically treated HPV-positive OPSCC.
Related Papers
- → Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer(2010)19 cited
- → Survival Effects of Radiotherapy on Patients Newly Diagnosed with Distant Metastatic Nasopharyngeal Carcinoma in Non-High-Incidence Areas(2021)6 cited
- STUDY ON THE EFFECTS OF RADIOTHERAPY ON T-CELL SUBGROUPS OF THE MALIGNANT TUMOR PATIENTS(2000)
- Comparison of the effects between three different therapy methods for non-small cell lung cancer.(2002)
- → Radiotherapy(2008)